Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: Comparison with other drugs

Pharmacology

Volumn 70, Issue 2, 2004, Pages 68-73

  Wajima, Teruaki ^a   Beguier, Beatrice ^a   Yaguchi, Masafumi ^a  

^a Aventis Pharma Ltd   (Japan)

Author keywords

Arrhythmias; Infarct size; Ischemia; Na+ H+ exchange; Nicorandil; Nifedipine; Propranolol; Reperfusion

Indexed keywords

CARIPORIDE; NICORANDIL; NIFEDIPINE; PROPRANOLOL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; GUANIDINES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NICORANDIL; NIFEDIPINE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; SULFONES; TACHYCARDIA, VENTRICULAR;

EID: 0348048850     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074670     Document Type: Article

References (22)

1. Karmazyn M: Ischemic and reperfusion injury in the heart: Cellular mechanisms and pharmacological interventions. Can J Physiol Pharmacol 1991;69:719-730.
2. + exchange and its inhibition in cardiac ischemia and reperfusion. Basic Res Cardiol 1993;88:443-455.
3. Levitsky J, Gurell D, Frishman WH: Sodium ion/hydrogen ion exchange inhibition: A new pharmacologic approach to myocardial ischemia and reperfusion injury. J Clin Pharmacol 1998;38:887-897.
4. Avkiran M: Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol 1999;83:10G-18G.
5. 2+ exchange. Circ Res 1989;65:1045-1056.
6. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W, Weichert A, Scholkens BA: Protective effects of HOE642, a selective sodium hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 1995;29:260-268.
7. + exchange inhibitor, on ventricular arrhythmias in animal hearts. Eur J Pharmacol 1996;317:309-316.
8. + exchange inhibitor, on reperfusion arrhythmias in rat hearts. Eur J Pharmacol 1997;339:121-127.
9. Linz W, Albus U, Crause P, Jung A, Weichert A, Scholkens BA, Scholz W: Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE642). Clin Exp Hypertens 1998;20:733-749.
10. +-exchange inhibition in regionally ischemic, reperfused porcine hearts. J Cardiovasc Pharmacol 1997;30:235-240.
11. Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White MD, Willerson JT, Jessel A: Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: Main results of the GUARDIAN trial. Circulation 2000;102:3032-3038.
12. ATP channel in rabbits. Int J Cardiol 1997;62:181-190.
13. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B: The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988;22:447-455.
14. Campbell CA, Parratt JR: The effects of β-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anesthetized rats. Br J Pharmacol 1983;79:939-946.
15. Takusagawa M, Komori S, Matsumura K, Osada M, Kohno I, Umetani K, Ishihara T, Sawanobori T, Ijiri H, Tamura K: The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats. J Cardiovasc Pharmacol Ther 2000; 5:105-112.
16. Bernauer W: The effect of β-adrenoceptor blocking agents on evolving myocardial necrosis in coronary ligated rats with and without reperfusion. Naunyn-Schmiedebergs' Arch Pharmacol 1985;328:288-294.
17. Vatner SF, Hintze TH: Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs. Circulation 1982;66: 579-588.
18. Crome R, Hearse DJ, Manning AS: Ischemia-and reperfusion-induced arrhythmias: Beneficial actions of nifedipine. J Cardiovasc Pharmacol 1986;8:1249-1256.
19. Parratt JR, Coker SJ: Cardioprotection with calcium antagonists by suppression of early ischaemia and reperfusion-induced arrhythmias. Eur Heart J 1983;4(suppl C):49-54.
20. ATP channel activation results in antiarrhythmic effect during experimental myocardial ischemia/reperfusion in anesthetized rabbits. Eur J Pharmacol 2002;437:165-171.
21. Sheridan DJ, Penkoske PA, Sobel BE, Corr PB: Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest 1980;65:161-171.
22. Corbalan R, Verrier RL, Lown B: Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am Heart J 1976;92:223-230.